209 related articles for article (PubMed ID: 37781028)
1. Low expression of m6A reader YTHDC1 promotes progression of ovarian cancer via PIK3R1/STAT3/GANAB axis.
Wang X; Chen Q; Bing Z; Zhou S; Xu Z; Hou Y; Zhao Y; Zhao S; Wang T
Int J Biol Sci; 2023; 19(14):4672-4688. PubMed ID: 37781028
[No Abstract] [Full Text] [Related]
2. The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection.
Yin F; Liu K; Peng W; Jiang D; Zhang H; Guo P; Wu Y; Zhang X; Sun C; Wang Y; Wang H; Han Y
Oxid Med Cell Longev; 2023; 2023():3918393. PubMed ID: 36819785
[TBL] [Abstract][Full Text] [Related]
3. YTHDC1 maintains trophoblasts function by promoting degradation of m6A-modified circMPP1.
Wang D; Guan H; Xia Y
Biochem Pharmacol; 2023 Apr; 210():115456. PubMed ID: 36780989
[TBL] [Abstract][Full Text] [Related]
4. Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development.
Kasowitz SD; Ma J; Anderson SJ; Leu NA; Xu Y; Gregory BD; Schultz RM; Wang PJ
PLoS Genet; 2018 May; 14(5):e1007412. PubMed ID: 29799838
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of m6A-factors METTL3, ALKBH5, and YTHDC1 alters HPV16 mRNA splicing.
Cui X; Nilsson K; Kajitani N; Schwartz S
Virus Genes; 2022 Apr; 58(2):98-112. PubMed ID: 35190939
[TBL] [Abstract][Full Text] [Related]
6. KAP1 stabilizes MYCN mRNA and promotes neuroblastoma tumorigenicity by protecting the RNA m
Yang Y; Zhang Y; Chen G; Sun B; Luo F; Gao Y; Feng H; Li Y
J Exp Clin Cancer Res; 2024 May; 43(1):141. PubMed ID: 38745192
[TBL] [Abstract][Full Text] [Related]
7. m
Liang D; Lin WJ; Ren M; Qiu J; Yang C; Wang X; Li N; Zeng T; Sun K; You L; Yan L; Wang W
Autophagy; 2022 Jun; 18(6):1318-1337. PubMed ID: 34657574
[TBL] [Abstract][Full Text] [Related]
8. Low Expression of YTH Domain-Containing 1 Promotes Microglial M1 Polarization by Reducing the Stability of Sirtuin 1 mRNA.
Zhou H; Xu Z; Liao X; Tang S; Li N; Hou S
Front Cell Neurosci; 2021; 15():774305. PubMed ID: 34975410
[TBL] [Abstract][Full Text] [Related]
9. KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells.
Shan M; Liu D; Sun L; Yang M; He M; Zhang Y; Xiang L; Lu L; He H; Niu D; Chen L; Li S; Chen A; He F; Wang Y; Lian J
Cancer Lett; 2024 Mar; 584():216598. PubMed ID: 38224863
[TBL] [Abstract][Full Text] [Related]
10. A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication.
Sheng Y; Wei J; Yu F; Xu H; Yu C; Wu Q; Liu Y; Li L; Cui XL; Gu X; Shen B; Li W; Huang Y; Bhaduri-McIntosh S; He C; Qian Z
Blood; 2021 Dec; 138(26):2838-2852. PubMed ID: 34255814
[TBL] [Abstract][Full Text] [Related]
11. Nuclear m6A reader YTHDC1 promotes muscle stem cell activation/proliferation by regulating mRNA splicing and nuclear export.
Qiao Y; Sun Q; Chen X; He L; Wang D; Su R; Xue Y; Sun H; Wang H
Elife; 2023 Mar; 12():. PubMed ID: 36892464
[TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine-modified circPLPP4 sustains cisplatin resistance in ovarian cancer cells via PIK3R1 upregulation.
Li H; Lin R; Zhang Y; Zhu Y; Huang S; Lan J; Lu N; Xie C; He S; Zhang W
Mol Cancer; 2024 Jan; 23(1):5. PubMed ID: 38184597
[TBL] [Abstract][Full Text] [Related]
13. Enhancer RNA m6A methylation facilitates transcriptional condensate formation and gene activation.
Lee JH; Wang R; Xiong F; Krakowiak J; Liao Z; Nguyen PT; Moroz-Omori EV; Shao J; Zhu X; Bolt MJ; Wu H; Singh PK; Bi M; Shi CJ; Jamal N; Li G; Mistry R; Jung SY; Tsai KL; Ferreon JC; Stossi F; Caflisch A; Liu Z; Mancini MA; Li W
Mol Cell; 2021 Aug; 81(16):3368-3385.e9. PubMed ID: 34375583
[TBL] [Abstract][Full Text] [Related]
14. Endothelial downregulation of nuclear m6A reader YTHDC1 promotes pulmonary vascular remodeling in sugen hypoxia model of pulmonary hypertension.
Zheng H; Wu D; Chen X; He W; Hua J; Li Q; Ji Y
Heliyon; 2024 Feb; 10(3):e24963. PubMed ID: 38318069
[TBL] [Abstract][Full Text] [Related]
15. YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway.
Li W; Ye K; Li X; Liu X; Peng M; Chen F; Xiong W; Wang Y; Zhu L
J Exp Clin Cancer Res; 2022 Aug; 41(1):250. PubMed ID: 35974388
[TBL] [Abstract][Full Text] [Related]
16. MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway.
Cao D; Ge S; Li M
J Bone Oncol; 2022 Apr; 33():100412. PubMed ID: 35198364
[TBL] [Abstract][Full Text] [Related]
17. N6-methyladenosine reader protein YTHDC1 regulates influenza A virus NS segment splicing and replication.
Zhu Y; Wang R; Zou J; Tian S; Yu L; Zhou Y; Ran Y; Jin M; Chen H; Zhou H
PLoS Pathog; 2023 Apr; 19(4):e1011305. PubMed ID: 37053288
[TBL] [Abstract][Full Text] [Related]
18. NAT10 mediated ac4C acetylation driven m
Mei Z; Shen Z; Pu J; Liu Q; Liu G; He X; Wang Y; Yue J; Ge S; Li T; Yuan Y; Yang L
Cell Commun Signal; 2024 Jan; 22(1):51. PubMed ID: 38233839
[TBL] [Abstract][Full Text] [Related]
19. Gene Signatures and Prognostic Values of m6A RNA Methylation Regulators in Ovarian Cancer.
Han X; Liu J; Cheng G; Cui S
Cancer Control; 2020; 27(1):1073274820960460. PubMed ID: 32951457
[TBL] [Abstract][Full Text] [Related]
20. ALKBH5 activates FAK signaling through m6A demethylation in
Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W
Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222
[No Abstract] [Full Text] [Related]
[Next] [New Search]
